Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 19320305)

1.

Helical intravitreal triamcinolone acetonide implant: a 6-month surgical feasibility study in rabbits.

Mello-Filho PA, Guven D, Beeley NR, de Juan E Jr, Erickson SR.

Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr;40(2):160-8.

PMID:
19320305
2.

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.

Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ.

Ophthalmology. 2009 May;116(5):902-11; quiz 912-3. doi: 10.1016/j.ophtha.2009.02.002. Review.

PMID:
19410949
3.

Corticosteroid intravitreal implants.

de Smet MD.

Dev Ophthalmol. 2012;51:122-33. doi: 10.1159/000336330. Epub 2012 Apr 17. Review.

PMID:
22517210
4.

The use of intraocular corticosteroids.

Kiernan DF, Mieler WF.

Expert Opin Pharmacother. 2009 Oct;10(15):2511-25. doi: 10.1517/14656560903160671. Review.

PMID:
19761356
5.

Intraocular sustained-release delivery systems for triamcinolone acetonide.

Mansoor S, Kuppermann BD, Kenney MC.

Pharm Res. 2009 Apr;26(4):770-84. doi: 10.1007/s11095-008-9812-z. Epub 2009 Jan 28. Review.

PMID:
19184374
6.

[Intravitreal injections of corticoids].

Demols P.

Bull Soc Belge Ophtalmol. 2007;(304):117-23. Review. French.

PMID:
17718236
7.
8.

Drug delivery implants in the treatment of vitreous inflammation.

Wang J, Jiang A, Joshi M, Christoforidis J.

Mediators Inflamm. 2013;2013:780634. doi: 10.1155/2013/780634. Epub 2013 Sep 28. Review.

9.

[Intravitreal triamcinolone for diabetic macular oedema. Method and complications].

Zamfir C.

Oftalmologia. 2009;53(1):100-5. Review. Romanian.

PMID:
19569613
10.

[Retina and glaucoma: therapeutic considerations].

Aptel F, Denis P.

J Fr Ophtalmol. 2008 Jul;31(6 Pt 2):2S61-4. Review. French.

11.

Visualizing vitreous in vitrectomy by triamcinolone.

Sakamoto T, Ishibashi T.

Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1153-63. doi: 10.1007/s00417-009-1118-2. Epub 2009 Jun 20. Review.

PMID:
19543906
12.

Intravitreal devices for the treatment of vitreous inflammation.

Christoforidis JB, Chang S, Jiang A, Wang J, Cebulla CM.

Mediators Inflamm. 2012;2012:126463. doi: 10.1155/2012/126463. Epub 2012 Sep 5. Review.

13.

Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers.

Guidetti B, Azéma J, Malet-Martino M, Martino R.

Curr Drug Deliv. 2008 Jan;5(1):7-19. Review.

PMID:
18220546
14.

Orthopedic implant used as drug delivery system: clinical situation and state of the research.

Pioletti DP, Gauthier O, Stadelmann VA, Bujoli B, Guicheux J, Zambelli PY, Bouler JM.

Curr Drug Deliv. 2008 Jan;5(1):59-63. Review.

PMID:
18220552
15.

Sustained-release drug implants for the treatment of intraocular disease.

Acharya N, Young L.

Int Ophthalmol Clin. 2004 Summer;44(3):33-9. Review. No abstract available.

PMID:
15211175
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk